Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01465841 · ClinicalTrials.gov registry record · NA
Study of the Penumbra Coil 400 System to Treat Aneurysm
A NA study, sponsored by Penumbra.
- Completed
- Registry status
- NA
- Development phase
- 517
- Enrollment target
NCT01465841 is a NA study that has completed, run by Penumbra. The registered enrollment target is 517 participants.
The verdict
NCT01465841, a NA study, has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- NA
- Development phase
- 517 participants
- Enrollment target
Study Summary
This is a prospective, multi-center study of patients with intracranial or peripheral aneurysms who are treated by the PC 400 System. The primary objective is to gather post market data on the Penumbra Coil 400 (PC 400) System in the acute treatment of intracranial and peripheral aneurysms. Approximately 2,000 patients with intracranial or peripheral aneurysms treated by the PC 400 System at up to 100 centers will be enrolled. Data for each patient are collected up to discharge or 3 days post-procedure, whichever occurs sooner. Long term follow-up to one year will be conducted in accordance to the standard of care at each participating hospital.
Interventions
- DEVICE PC 400 coils (Penumbra )
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 517 participants |
| Start Date | 2011-11 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01465841
The ClinicalTrials.gov registry entry for NCT01465841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 517 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PC 400 coils (Penumbra ) is the first listed.
NCT01465841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01465841 about?
NCT01465841 is a clinical study titled "Study of the Penumbra Coil 400 System to Treat Aneurysm". This is a prospective, multi-center study of patients with intracranial or peripheral aneurysms who are treated by the PC 400 System. The primary objective is to gather post market data on the Penumbra Coil 400 (PC 400) System in the acute treatment of intracranial and peripheral aneurysms. Approxim...
What is the current status of trial NCT01465841?
This trial is currently completed. It is a NA study. The enrollment target is 517 participants. The study started on 2011-11. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01465841?
The interventions under investigation include: PC 400 coils (Penumbra ) (DEVICE).
Who is sponsoring clinical trial NCT01465841?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.